Spirax: Organic Sales and Margin Growth Accelerates From H1; Shares Undervalued
Spirax confirmed its full-year guidance in a trading update for the four months ending October. Accelerating sales growth since the first half of the year has been broad-based across operating segments. Shares are trading 4% higher intraday.